Morningstar Investor users sign in here.

Company Profile

  • Business description

    Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company’s operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

  • Contact

    One Broadway
    14th Floor
    Cambridge MA 02142
    USA

    T: +1 857 357-7000

    https://www.nuvalent.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    106

Stocks News & Analysis

video

Top opportunities in the Aussie tech and AI space

Morningstar's Michael Malseed interviews First Sentier's Dawn Kanelleas and Maple-Brown Abbott's Phil Hudak. 
stocks

3 wide moat shares at five-star prices

Our analysts think these companies enjoy durable competitive advantages with the potential to last for at least 20 years. The shares also look cheap.
stocks

Undervalued ASX share bolsters acquisition firepower

We recommend shareholders participate in equity raise.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,002.30 13.50 -0.17%
CAC 40 7,628.80 57.23 0.76%
DAX 40 18,131.97 63.76 0.35%
Dow JONES (US) 38,834.86 56.76 0.15%
FTSE 100 8,191.29 49.14 0.60%
HKSE 18,258.96 343.41 1.92%
NASDAQ 17,862.23 5.21 0.03%
Nikkei 225 38,471.48 10.63 -0.03%
NZX 50 Index 11,679.35 88.05 -0.75%
S&P 500 5,487.03 13.80 0.25%
S&P/ASX 200 7,762.20 15.90 -0.20%
SSE Composite Index 3,019.53 10.71 -0.35%

Market Movers

Name
Last price
Change
% Change
Liontown Resources Ltd LTR 1.00 0.03 -2.45%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Red 5 Ltd RED 0.45 0.00 -0.56%
Pilbara Minerals Ltd PLS 3.22 0.05 -1.38%
Beach Energy Ltd BPT 1.46 0.07 -4.58%
Telstra Group Ltd TLS 3.59 0.01 -0.28%
Mirvac Group MGR 1.93 0.06 3.35%
Latin Resources Ltd LRS 0.19 0.01 -3.85%
Core Lithium Ltd CXO 0.09 0.00 -2.22%
Melbana Energy Ltd MAY 0.05 0.00 2.22%